CIK: 1709024 - Address: C/O Celldex Therapeutics, Inc., 53 Frontage Road, Suite 220, Hampton, NJ 08827
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

1/4/24 16:05
1/2/24
CLDXCelldex Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMartin Samuel BatesNJOSVP,CFOM.d302.780114435D
8/15/22 16:16
8/11/22
CLDXCelldex Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMartin Samuel BatesNJOSVP,CFOM.dm954.7502045724D
8/15/22 16:16
8/11/22
CLDXCelldex Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMartin Samuel BatesNJOSVP,CFOS.dm-73036.520-20-4524D
12/28/21 16:02
12/23/21
CLDXCelldex Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMartin Samuel BatesNJOSVP,CFOM.d405.68074024D
12/28/21 16:02
12/23/21
CLDXCelldex Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMartin Samuel BatesNJOSVP,CFOS.d-39942.000-10-2824D
11/17/21 16:02
11/15/21
CLDXCelldex Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMartin Samuel BatesNJOSVP,CFOM.d405.68073527D
11/17/21 16:02
11/15/21
CLDXCelldex Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMartin Samuel BatesNJOSVP,CFOS.d-41443.570-10-2627D
8/12/21 10:00
8/10/21
CLDXCelldex Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMartin Samuel BatesNJOSVP,CFOM.d1245.7802126729D
8/12/21 10:00
8/10/21
CLDXCelldex Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMartin Samuel BatesNJOSVP,CFOS.d-12445.250-3-929D
6/10/20 07:55
6/9/20
CLDXCelldex Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMartin Samuel BatesNJOSVP,CFOP303.0501099011D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact